3,4-Methylenedioxymethamphetamine
Sponsors
University Hospital, Basel, Switzerland, Parc de Salut Mar, University of Chicago, VA Loma Linda Health Care System, Germans Trias i Pujol Hospital
Conditions
Amphetamine-Related DisordersChronic Neuropathic PainCombat Stress DisordersHealthyHealthy SubjectsMDMA ('Ecstasy')Mood DisorderPost Traumatic Stress Disorder
Early Phase 1
Phase 1
Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)
CompletedNCT00990067
Start: 2009-11-30End: 2010-05-31Updated: 2013-01-25
Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
CompletedNCT01136278
Start: 2010-07-31End: 2010-12-31Updated: 2013-01-25
Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)
CompletedNCT01386177
Start: 2011-07-31End: 2012-01-31Updated: 2018-12-11
Emotional Effects of Methylphenidate and MDMA in Healthy Subjects
CompletedNCT01465685
Start: 2011-12-31End: 2013-01-31Updated: 2016-01-21
Abuse Liability and Human Pharmacology of Mephedrone
CompletedNCT02232789
Start: 2014-09-30End: 2014-12-31Updated: 2014-12-04
Effect of Stimulant Drugs on Social Perception
CompletedNCT03790618
Start: 2016-06-01End: 2018-08-01Updated: 2024-01-05
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
CompletedNCT04516902
Start: 2021-01-01End: 2022-08-22Updated: 2022-08-23
Effects of MDMA-like Substances in Healthy Subjects
CompletedNCT04847206
Start: 2021-12-01End: 2024-06-18Updated: 2024-08-14
Acute Effects of R- and S-MDMA in Healthy Subjects
CompletedNCT05277636
Start: 2022-10-01End: 2024-01-13Updated: 2024-01-17
Abuse Potential and Human Pharmacology of Methylone
NCT05488171
Start: 2021-12-01End: 2022-09-30Updated: 2022-08-08
Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
CompletedNCT05523401
Start: 2023-08-16End: 2024-11-05Updated: 2025-03-05
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
RecruitingNCT06884514
Start: 2025-04-03End: 2026-07-01Target: 24Updated: 2025-05-21
Phase 2
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
CompletedNCT04264026
Start: 2021-07-29End: 2025-05-01Updated: 2025-07-20
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
RecruitingNCT05790239
Start: 2025-03-01End: 2026-03-31Target: 40Updated: 2025-03-28
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
RecruitingNCT07301632
Start: 2026-01-30End: 2028-12-01Target: 40Updated: 2026-02-13